UBS AM’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-284,924
| Closed | -$479K | – | 2705 |
|
|
2025
Q1 | $479K | Buy |
284,924
+5,642
| +2% | +$9.48K | ﹤0.01% | 2508 |
|
|
2024
Q4 | $455K | Buy |
279,282
+25,383
| +10% | +$41.4K | ﹤0.01% | 2567 |
|
|
2024
Q3 | $1.06M | Buy |
253,899
+6,823
| +3% | +$28.4K | ﹤0.01% | 2366 |
|
|
2024
Q2 | $1.35M | Buy |
247,076
+163,729
| +196% | +$894K | ﹤0.01% | 2214 |
|
|
2024
Q1 | $833K | Buy |
83,347
+18,064
| +28% | +$181K | ﹤0.01% | 2098 |
|
|
2023
Q4 | $266K | Buy |
65,283
+7,688
| +13% | +$31.4K | ﹤0.01% | 2447 |
|
|
2023
Q3 | $223K | Buy |
57,595
+19,777
| +52% | +$76.5K | ﹤0.01% | 2496 |
|
|
2023
Q2 | $124K | Hold |
37,818
| – | – | ﹤0.01% | 2623 |
|
|
2023
Q1 | $124K | Sell |
37,818
-14,800
| -28% | -$48.4K | ﹤0.01% | 2623 |
|
|
2022
Q4 | $208K | Hold |
52,618
| – | – | ﹤0.01% | 2435 |
|
|
2022
Q3 | $316K | Sell |
52,618
-19,982
| -28% | -$120K | ﹤0.01% | 2483 |
|
|
2022
Q2 | $467K | Buy |
72,600
+48,000
| +195% | +$309K | ﹤0.01% | 2344 |
|
|
2022
Q1 | $203K | Hold |
24,600
| – | – | ﹤0.01% | 2676 |
|
|
2021
Q4 | $381K | Buy |
+24,600
| New | +$381K | ﹤0.01% | 2630 |
|